CONVERTIBLE PROMISSORY NOTEPathfinder Cell Therapy, Inc. • April 30th, 2013 • Orthopedic, prosthetic & surgical appliances & supplies
For value received, the undersigned, Pathfinder Cell Therapy, Inc., a Delaware corporation (the “Borrower”), hereby unconditionally promises to pay to the order of _____________ (the “Payee”), the principal sum of $_______ and 00/100 Dollars ($_________), together with interest to maturity (whether by lapse of time, acceleration or otherwise) on the balance of principal remaining from time to time outstanding at a rate per annum equal to 6%. Interest shall be calculated on the basis of a 360-day year and actual days.
Research Agreement – Extension No. 3Research Agreement • April 30th, 2013 • Pathfinder Cell Therapy, Inc. • Orthopedic, prosthetic & surgical appliances & supplies
We refer to our recent discussions regarding the research agreement between The University Court of the University of Glasgow (the University) and Pathfinder, LLC (now a wholly owned subsidiary of Pathfinder Cell Therapy, Inc., previously known as SyntheMed, Inc.) (the Company) (contract no. 49974/1) dated 23 March 2009, as extended by way of an extension letter from the University to the Company dated 19 April 2012 (the Research Agreement). Terms defined in the Research Agreement will have the same meaning where used herein.
